PLPL2_HUMAN - dbPTM
PLPL2_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID PLPL2_HUMAN
UniProt AC Q96AD5
Protein Name Patatin-like phospholipase domain-containing protein 2
Gene Name PNPLA2
Organism Homo sapiens (Human).
Sequence Length 504
Subcellular Localization Lipid droplet. Cell membrane
Single-pass type II membrane protein.
Protein Description Catalyzes the initial step in triglyceride hydrolysis in adipocyte and non-adipocyte lipid droplets. [PubMed: 15550674 Also has acylglycerol transacylase activity. May act coordinately with LIPE/HLS within the lipolytic cascade. Regulates adiposome size and may be involved in the degradation of adiposomes]
Protein Sequence MFPREKTWNISFAGCGFLGVYYVGVASCLREHAPFLVANATHIYGASAGALTATALVTGVCLGEAGAKFIEVSKEARKRFLGPLHPSFNLVKIIRSFLLKVLPADSHEHASGRLGISLTRVSDGENVIISHFNSKDELIQANVCSGFIPVYCGLIPPSLQGVRYVDGGISDNLPLYELKNTITVSPFSGESDICPQDSSTNIHELRVTNTSIQFNLRNLYRLSKALFPPEPLVLREMCKQGYRDGLRFLQRNGLLNRPNPLLALPPARPHGPEDKDQAVESAQAEDYSQLPGEDHILEHLPARLNEALLEACVEPTDLLTTLSNMLPVRLATAMMVPYTLPLESALSFTIRLLEWLPDVPEDIRWMKEQTGSICQYLVMRAKRKLGRHLPSRLPEQVELRRVQSLPSVPLSCAAYREALPGWMRNNLSLGDALAKWEECQRQLLLGLFCTNVAFPPEALRMRAPADPAPAPADPASPQHQLAGPAPLLSTPAPEARPVIGALGL
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
39N-linked_GlycosylationHAPFLVANATHIYGA
HCCEEEEECCEEECC
37.58UniProtKB CARBOHYD
74UbiquitinationAKFIEVSKEARKRFL
HHHHHHCHHHHHHHC
61.6421906983
74 (in isoform 1)Ubiquitination-61.6421890473
78UbiquitinationEVSKEARKRFLGPLH
HHCHHHHHHHCCCCC
55.3322817900
92UbiquitinationHPSFNLVKIIRSFLL
CCCHHHHHHHHHHHH
35.27-
100UbiquitinationIIRSFLLKVLPADSH
HHHHHHHHHCCCCCC
43.8221906983
100 (in isoform 1)Ubiquitination-43.8221890473
117PhosphorylationASGRLGISLTRVSDG
CCCCCEEEEEEECCC
23.1424719451
119O-linked_GlycosylationGRLGISLTRVSDGEN
CCCEEEEEEECCCCC
23.4129351928
176PhosphorylationISDNLPLYELKNTIT
CCCCCEEEEEECEEE
19.7827642862
179UbiquitinationNLPLYELKNTITVSP
CCEEEEEECEEEECC
39.8521963094
224 (in isoform 1)Ubiquitination-54.4221890473
224UbiquitinationRNLYRLSKALFPPEP
HHHHHHHHHHCCCCH
54.4223000965
239UbiquitinationLVLREMCKQGYRDGL
HHHHHHHHCCHHHHH
45.5127667366
287PhosphorylationESAQAEDYSQLPGED
HHHHHHCHHHCCCCC
6.9928796482
288PhosphorylationSAQAEDYSQLPGEDH
HHHHHCHHHCCCCCC
37.2528796482
349PhosphorylationLESALSFTIRLLEWL
HHHHHHHHHHHHHHC
11.2124719451
367UbiquitinationPEDIRWMKEQTGSIC
CHHHHHHHHHHHCHH
39.45-
372PhosphorylationWMKEQTGSICQYLVM
HHHHHHHCHHHHHHH
24.47-
391PhosphorylationKLGRHLPSRLPEQVE
HHHCCCCCCCHHHHH
53.4624719451
404PhosphorylationVELRRVQSLPSVPLS
HHHEECCCCCCCCHH
39.1123927012
407PhosphorylationRRVQSLPSVPLSCAA
EECCCCCCCCHHHHH
41.4830266825
411PhosphorylationSLPSVPLSCAAYREA
CCCCCCHHHHHHHHH
8.8130266825
415PhosphorylationVPLSCAAYREALPGW
CCHHHHHHHHHCCHH
7.1723403867
428PhosphorylationGWMRNNLSLGDALAK
HHHHCCCCHHHHHHH
32.2219664994
435UbiquitinationSLGDALAKWEECQRQ
CHHHHHHHHHHHHHH
56.8621963094
476PhosphorylationPAPADPASPQHQLAG
CCCCCCCCCCCCCCC
30.4029255136
490PhosphorylationGPAPLLSTPAPEARP
CCCCCCCCCCCCCCC
24.3621712546

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
404SPhosphorylationKinaseFAM20CQ8IXL6
Uniprot
404SPhosphorylationKinasePKA-Uniprot

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
404SPhosphorylation

22733971
404SPhosphorylation

22733971

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of PLPL2_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
PEDF_HUMANSERPINF1physical
17032652
GBF1_HUMANGBF1physical
21789191
ABHD5_HUMANABHD5physical
17189257
PEX14_HUMANPEX14physical
28514442
TRXR2_HUMANTXNRD2physical
28514442
TIM29_HUMANC19orf52physical
28514442
RFWD2_HUMANRFWD2physical
27658392

Drug and Disease Associations
Kegg Disease
H01297 Neutral lipid storage disease with myopathy
OMIM Disease
Note=Genetic variations in PNPLA2 may be associated with risk of diabetes mellitus type 2.
610717
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of PLPL2_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-428, AND MASSSPECTROMETRY.

TOP